On-going projectsLogo Cohorte EGEA

Working group «Occupational and Domestic Exposures»

Project investigator: N Le Moual, V Siroux
Places of project executions: Equipe d’épidémiologie respiratoire intégrative, CESP, Villejuif
Funding: Université Paris-Saclay, Bourse de Thèse, Emilie Pacheco Da Silva
Partners: ‘Phénotypes’ group

The impact of cleaning product used during home cleaning tasks on asthma symptoms has been studied among women from the second EGEA survey (EGEA2: 2003-2007). These analyses suggested a deleterious role of a weekly use of products in spray form (window, air freshener …) and bleach on asthma. At EGEA2, around 50% of the women use weekly irritants (bleach, ammonia, solvents, decalcifiers) or products in spray forms. At EGEA3, only 40% of the women reported a weekly use of sprays, while the weekly use of irritants was similar to EGEA2.
The evolution of use of irritant cleaning products (bleach, ammonia, solvents, …) and on spray form at both surveys (EGEA2 & EGEA3: 2011-2013) will be studied in relation with the evolution of asthma symptoms on the same period. The project specifically focused on evaluation of the impact of a weekly use of these products at both surveys, especially for sprays (compared to non-weekly use at both surveys) on women respiratory health.
This project will evaluate the impact of long-term weekly use of household cleaning products on respiratory health, and may provide important information to improve respiratory health.

Project investigator: N Le Moual, E Pacheco Da Silva
Places of project executions: Equipe d’épidémiologie respiratoire intégrative, CESP, Villejuif
Funding: DIM Qi2, bourse de Master2, Eddy Dohoukpe
Partners: ‘Biology’ group

Evidence regarding the deleterious impact of the weekly use at home of cleaning products on asthma increased, especially with results from the EGEA cohort. Compounds of cleaning products might be ‘irritants’ (which may induce airways irritation) or sensitizers (which may induce an allergic reaction), but the underlying mechanisms by which these compounds exacerbate or induce asthma are still poorly known. In this context, the project aims to study associations between irritants (especially bleach) or sensitizers (especially in sprays) and different asthma profiles defined based on clinical and biological characteristics.
This work may help to better understand mechanism involved in the deleterious impact of cleaning products on respiratory health, and potentially to improve the clinical management of the patients according to the type of exposure and asthma profile.

Project investigator: O Dumas, R Nadif
Places of project executions: Equipe d’épidémiologie respiratoire intégrative, CESP, Villejuif
Funding: Anses ; projet IMMUCAP (PI : Saadia Kerdine-Römer, UMR-S 996 ; Co-I : N Le Moual, R Nadif, O Dumas, Inserm U1018-CESP)
Partners: ‘Biology’ group

Cleaning products and disinfectants are complex mixture of chemical substances. Quaternary ammonium compounds are commonly present in these products. Exposure to quaternary ammonium compounds is strongly suspected in the development of allergic diseases. However, immuno-dependant mechanism involved during exposure to such products (allergic mechanism) have been scarcely studied. A better understanding of these mechanisms could be useful to classify quaternary ammonium compounds according to their toxicity level and to establish recommendation regarding exposure level limits. This topic will be studied in the context of the IMMUCAP project. In EGEA, the aim will be to study the association between occupational exposure to quaternary ammonium compounds and immunization against these compounds, evaluated through two biological markers: Immunoglobulin E (IgE) et G (IgG) anti-quaternary ammonium. For these analyses, 724 participants from EGEA2 have been selected including a group of participants without occupational exposure and a group of health care workers, who frequently use disinfectants including quaternary ammonium compounds. Statistical analyses will be performed to test the hypothesis of higher level of IgE and IgG anti-quaternary ammonium among exposed participants.

Working group «Biology»

Project investigator: B Jacquemin et R Nadif
Places of project executions: Equipe d’épidémiologie respiratoire intégrative, CESP, Villejuif
Funding: Université Paris-Saclay, Bourse de Thèse, Marine Savouré, aide financière individuelle à la formation par la recherche financée par l’agence de l’environnement et la maitrise de l’énergie (ADEME)
Partners: groupe ‘Phénotype’

Rhinitis is a disease characterized by inflammation of the nasal cavity and is associated with symptoms such as sneezing, rhinorrhoea (i.e. a runny nose), congestion, and/or nasal pruritus (i.e. an itchy nose). Often trivialized, it is nevertheless very common, and has an individual and societal impact. There are different forms of rhinitis called endotypes which have their own characteristics depending on the biological and mechanistic pathways involved.
However, until now, rhinitis endotypes have been little studied in epidemiological studies. The objective of this project is therefore to identify and study the endotypes of rhinitis. For this purpose, an algorithmic approach (unsupervised approach) will be used based on biological data and data from the questionnaires of the EGEA2 participants. The identification and characterisation of rhinitis endotypes will provide new knowledge on rhinitis and thus potentially better prevention and treatment.

Project investigator: F Zerimech, R Matran et R Nadif
Places of project executions: Laboratoire de Biochimie Biologie Moléculaire, Centre de Biologie Pathologie, CHU de Lille
Funding: ANSES PNR-EST 2017 (R. Nadif)
Partners: /

Asthma is a common, heterogeneous and multifactorial chronic respiratory disease. Among the risk factors for asthma, environmental factors play an important role but the mechanisms by which they affect respiratory health are still poorly understood. However, some studies suggest interactions between the biological pathways of inflammation, oxidative and nitrosative stress and allergy. The inflammatory cells that infiltrate the airways produce several pro-inflammatory mediators that interact with each other to form a final stable compound, the 3-nitrotyrosine (3-NT), which has been detected in serum, bronchoalveolar lavage fluid, lung tissue, and exhaled air condensate. The exhaled breath condensate is a fluid that originates from the tracheo-bronchial tree and alveoli, obtained by a non-invasive and inexpensive technique. It is composed of more than 99% water vapour, in which are dissolved substances that reflect the inflammatory status of the bronchopulmonary system. Our project aims to quantify 3-NT in the exhaled breath condensate of 1000 adults from the EGEA study and to study its associations with asthma.

Project investigator: JM Lo Guidice, R Matran et R Nadif
Places of project executions: Lille
Funding: NA
Partners: /

To be completed

Working group «Nutrition, physical activity»

Project investigator: Raphaëlle Varraso
Places of project executions: INSERM UMR-S 1018, Center for Research in Epidemiology and Population Health (CESP), Integrative Respiratory Epidemiology team, Villejuif
Funding: NA
Partners: ‘Phenotypes’ group

Asthma is a multifactorial disease of the airways, with both genetic and environmental determinants. The prevalence of asthma has nearly doubled over the last decades, especially in Westernized countries and developing countries with rapid urbanization. This cannot be explained by genetics alone and it has been hypothesized that this increase is a consequence of changing environmental and/or lifestyle factors, including a modification of dietary habits (less fruit and vegetables, and more processed and ready-to-eat food). Up to now, the impact of specific foods and/or dietary patterns on asthma remains largely unknown.
As we do not consume isolated foods (such as apple) or nutrients (such as vitamin C), but meals consisting of a complex combination of foods, which themselves contain nutrients, studying overall diet through dietary scores has been proposed to evaluate dietary patterns. The most famous is the Mediterranean diet score which is based on a high consumption of fruits and seasonal vegetables, high consumption of whole grains cereals (including pasta, rice and bread), high consumption of legumes (lentils, chickpeas, beans...), fatty fish (sardines, mackerel, herring, salmon), fats from vegetable oils such as olive oil and nuts (walnuts, hazelnuts, almonds, pistachios...), and limited intake of red meat, dairy products (cheese, butter, cream), and refined and processed products (breakfast cereals, industrial bread, ready-made meals). However, research in nutritional epidemiology is evolving regarding knowledge between diet and health, and new dietary scores are frequently developed.

1) Plant-based diet (Master 2 AgroParisTech internship, 2021: Malek Fathallah; supervisors: Raphaëlle Varraso, Annabelle Bédard).
The term “plant-based diets” encompasses a wide range of dietary patterns that contain lower amounts of animal products and higher amounts of plant products, and are becoming increasingly popular. Current evidence clearly emphasizes the importance of a healthful plant-based dietary pattern because of its lower risk of diet-related chronic diseases, but also because of its lower environmental impact. Several dietary scores have been recently proposed in the literature to evaluate the nutritional quality of plant-based diets. It has been shown that a plant-based diet with low nutritional quality such as, for example a diet with a low intake of red meat but high intakes of chips and/or biscuits (unhealthful plant-based foods) was associated with a greater risk for cardiovascular diseases, underlying the importance of a differentiation of plant foods.
Thanks to detailed data on diet collected at EGEA2, the project aims to develop several dietary scores to evaluate the nutritional quality of plant-based diet, and to study their relationship with asthma symptoms and the evolution of asthma symptoms over time (between EGEA2 and EGEA3). We hypothesize that a greater adherence to a healthful version of a plant-based diet is associated with a decreased asthma symptoms risk, whereas adherence to an unhealthful version is associated with an increased asthma symptoms risk.

2) Diet with antioxidant or inflammatory capacity
Both oxidative stress and inflammation are two biological mechanism of interest in asthma. However, diet can be an important source of both oxidants and/or antioxidants, and of foods with inflammatory capacity. Dietary scores have been proposed to assess specific biological properties of diet, such as the dietary total antioxidant capacity (TAC) and the dietary inflammatory index (DII).
These dietary scores will be developed in collaboration with other nutritional epidemiology teams with which long-standing collaborations exist (Exposome and Heredity team, Inserm U1018, Villejuif; Nutritional Epidemiology Research team, Inserm U1153, Bobigny; Department of Nutritional Epidemiology, Harvard TH Chan School of Public Health, Boston, USA), and will be studied in relation with asthma.

Working group «Genetic»

Project investigator: Emmanuelle Bouzigon
Places of project executions: Université Paris Cité, Inserm UMR1124, Equipe Epidémiologie génomique des maladies multifactorielles
Funding: ANR GenCAST
Partners: Hanna Julienne, Institut Pasteur

Asthma is a heterogeneous disease with a large spectrum of clinical expression reflecting the multiple underlying physiopathological mechanisms or endotypes. Recent studies leveraged phenotypic and biological data to identify subtypes of individuals with asthma but have not included genetic data as a driving component of clustering process. This project aims to identify asthma endotypes by using clustering methods applied to genetic polymorphisms associated with multiple phenotypes involved in the pathophysiology of the disease. This project will allow better understanding of the genetic structure underlying asthma endotypes, and identifying more precisely the links between molecular pathways and clinical phenotypes, a key step towards the improvement and personalization of asthma management.

Project investigator: Florence Demenais
Places of project executions: Université Paris Cité, Inserm UMR1124, Equipe Epidémiologie génomique des maladies multifactorielles
Funding: ANR MetabAsthma
Partners: Dominique Gauguier, Inserm UMR1124

Metabolomics is a powerful molecular phenotyping technology used to detect and quantify several thousands of metabolic compounds in a biological sample. Metabolites represent the intermediate products of a number of physiological processes that are influenced by biological mechanisms of disease and environmental factors.
The main objective of this project is to identify the metabolites (measured in plasma using 1H Nuclear Magnetic Resonance (NMR) and mass spectrometry (MS)) associated with asthma and asthma-associated phenotypes, and to integrate genetic and metabolomic data in order to establish a causal link between metabolites and disease (phenotypes). For that purpose, 1- we will conduct metabolome-wide association studies (MWAS) to detect association between metabolite profiles signals and asthma (or other phenotypes and potentially environmental factors); 2- we will characterize the genetic control of metabolites associated with asthma (or other phenotype) through genome-wide association studies; 3- we will establish a clausal link between metabolites and disease (asthma or other phenotype), by using Mendelian Randomization or causal inference models. Then, further validation of candidate metabolites and characterization of their function will be done in rodent models of asthma. Finally, we will do integrative analysis of various omics data, genetic, epigenomic, metabolomic data and gene expression data (available from public data bases) through extension of network-based methods and other approaches.
It will deliver novel knowledge of diagnostic metabolic biomarkers, including metabolic products of gut microbial activity, at the crossroads between host susceptibility alleles, lifestyle and environmental exposures. This will allow characterizing metabolites as biomarkers of disease prevention or prognosis.

Project investigator: Florence Demenais
Places of project executions: Multicentric project with different locations (see the list of partners). The French part of the EGEA study is conducted in the UMR-1124 (Inserm, Université Paris Cité, Director: Robert Barouki)
Funding: Joint Transnational Call for Epigenomics of Complex Diseases. Three funding agencies: ANR (France) /CIHR (Canada) /BMBF (Germany). The funding for partner 3 (EGEA study) comes from the ANR (356 286€)
Partners: 1) Coordinateur Principal (PI): Tomi Pastinen, McGill University, Montreal, Quebec, Canada, H3A 0G1. 2)Responsable d’équipe (Team Leader): Catherine Laprise, Université du Québec à Chicoutimi (UQAC), Chicoutimi, Québec, Canada, G7H 2B1. 3) Responsable d’équipe (Team Leader): Florence Demenais, UMR-946, Inserm, Université Paris Diderot (devenue Université Paris Cité), 75010, Paris France. 4) Responsable d’équipe (Team Leader): Pierre Bougnères, UMR-986, Hôptal Bicêtre, Université Pari Sud, Le Kremlin Bicêtre, France. 5) Responsable d’équipe (Team Leader): Reiner Siebert, Institute of Human Genetics, University Hospital of Ulm, Ulm, Germany. 6) Responsable d’équipe (Team Leader): Ezio Bonifacio, Center for Regenerative Therapies, Technical University Dresden, Dresden German

Type 1 diabetes (T1D) and asthma are both commons diseases with an important immune component and a high prevalence in Westernized countries. Several studies have suggested that common factors could explain susceptibility in developing one or another. In both these diseases, naïve CD4+ T lymphocytes (CD4+) are important actors by differentiating themselves towards a specific subtype in T1D and another one in asthma. These diseases also result from the effects of many genes and environmental factors. Despite the considerable efforts to characterize the genetic determinants of asthma, genetic factors identified to date explain only a part of its genetic component, with a number of associated loci shared by asthma and autoimmune diseases (including T1D). studying their specific epigenome profile (principally the methylome) should allow a better understanding of the complex mechanism underlying these diseases.
The RESET-AID consortium’s overall aim is to provide the first fully characterized epigenomic profiling of asthma and T1D risk and progression. The consortium members are at the forefront in the genetics and pathophysiology for asthma and T1D and have built significant resources to allow studies of risk factors in cohorts. To reach the overall aim, the consortium proposed to use a standardized sequencing approach (based on targeted bisulfite sequencing, MCC-seq) between all cohorts (Canadian and French) to study the methylome of T1D and asthma in whole blood samples. To better understand the biological impact of these results, they proposed to perform analyses in naïve CD4+ T cell (CD4+) samples and to develop methodological and analytical approaches to facilitate reproducible analyses in small samples (eg, single cells) and to contextualize the epigenome results using biological networks.

Working group «Phenotypes»

Project investigator: Valérie Siroux
Places of project executions: Equipe d’épidémiologie environnementale appliquée au développement et à la santé repiratoire, Institut pour l’Avancée des Biosciences, Grenoble; Université Paris Cité, Inserm UMR1124, Equipe Epidémiologie génomique des maladies multifactorielles
Funding: ANR-19-CE36-0005-01_NIRVANA
Partners: EGEA genetic group (Emmanuelle Bouzigon, Inserm U1124; Paris); Division of Immunopathology, Department of Pathophysiology and Allergy Research, Medical University of Vienna (R Valenta)

Asthma is a frequent disabling chronic respiratory disease associated with high global costs ($81.9 billion in USA). In France, asthma prevalence in children is 11%. Asthma cannot be cured; therefore, prevention is thought to be the long-term solution for the asthma epidemic. Asthma results from interplays between environmental, lifestyle, genetic and epigenetic factors. For two environmental factors, respiratory allergens and respiratory viruses, strong association with asthma incidence or exacerbations is well documented. A few previous observations suggest that the host genotype plays an important role in the immune response of individual allergens and rhinovirus (RV), but these studies were limited in the assessment of allergen-specific and RV-specific immune responses. New technologies based on microarrays allow accurate and comprehensive characterization of hundreds allergen-specific and RV-specific antibody responses, and offer new avenues in the asthma epidemiological research.
Our main objective is to identify allergen-specific and RV-specific antibody responses associated with asthma and the host genomic determinants of these immune responses. The central hypothesis that the host genotype plays an important role in the effects of respiratory allergens and viruses in asthma is supported by several observations, but has still never been deeply addressed.
A detailed knowledge of the most harmful allergens and RV strains is mandatory for an appropriate diagnostic and preventive approach. Through detailed analysis of genetic factors underlying the antibody responses to allergens and RV involved in the development of asthma, the project will have major implications in deepening knowledge of the population at risk for allergic asthma and RV-induced asthma, which in turn will impact on the asthma management and prevention.

Project investigator: Valérie Siroux
Places of project executions: Equipe d’épidémiologie environnementale appliquée au développement et à la santé repiratoire, Institut pour l’Avancée des Biosciences, Grenoble; CHU-Grenoble-Alpes, Grenoble; HCL Lyon; CHU de Montpellier; Groupe Hospitalier Bichat-Claude bernard, Paris; APHM Marseille; INSERM UMR-S 1018, CESP, équipe d’épidémiologie respiratoire intégrative, Villejuif ; Université Paris Cité, Inserm UMR1124, Equipe Epidémiologie génomique des maladies multifactorielles
Funding: ANR-21-CE36-0008-01 “EGEA_30YEARS”
Partners: Team of Environmental Epidemiology to the Development and Respiratory Health, Institute for Advanced Biosciences, Grenoble; CHU-Grenoble-Alpes, Grenoble; HCL Lyon; CHU de Montpellier; Groupe Hospitalier Bichat-Claude Bernard, Paris; APHM Marseille; INSERM UMR-S 1018, CESP, équipe d’épidémiologie respiratoire intégrative, Villejuif ; Université Paris Cité, Inserm UMR1124, Equipe Epidémiologie génomique des maladies multifactorielles ; PAARCC Inserm U970, Paris

Asthma and cardiovascular (CV) diseases are two common conditions with important public health and economic burden. Despite growing evidence that asthma is associated with increased risk of major CV events, the mechanisms by which asthma may affect the risk for CV events remain poorly understood. In particular, whether asthma and CV diseases share common etiological processes (such as anthropometric, lifestyle, social, environmental and/or genetic factors), or whether CV diseases are a consequence of some asthma characteristics (such as systemic inflammation) remains unknown. The limited knowledge on this mechanism hampers preventive intervention.
We aim to disentangle the complex association between asthma and early markers of CV risk, in order to provide new directions in clinical management of patients with asthma and in preventive intervention to prevent CV comorbidities in asthma.
To carry out this research program it is necessary to accurately collect new information of each participant of the EGEA cohort. Thus, a 4th follow-up of the EGEA cohort, 30 years after the cohort was initiated is undergoing.
Our multidisciplinary program will provide tools for identifying and prioritizing determinants of CV risk in asthma and feed into risk prediction, new directions in clinical management as well as development of preventive interventions in asthma. Therefore, this project may unravel actionable levers to avoid CV comorbidities in asthma.

Working group «Climate and air pollution»

Project investigator: J Lepeule
Places of project executions: IAB, Inserm U1209, Equipe Epidémiologie environnementale appliquée au développement et à la santé respiratoire, Grenoble
Funding: Fondation de France CLIMATHES
Partners: groupe ‘Phénotypes’ (V Siroux)

Climate change is a major challenge for public health. Increasing temperatures and extreme weather events are sources of population health hazards, especially for the most vulnerable. The few studies that explored the links between ambient temperature and ventilatory function show contradictory results. However, they seem to agree on the fact that individuals suffering from asthma represent a vulnerable population. The CLIMATHES project seeks to test the hypothesis that higher temperatures and humidity levels are associated with lower ventilatory function in the short term.
The analysis will use data from all participants of the EGEA cohort who contributed to the first (EGEA1) or second (EGEA2) follow-up of the study. Exposures to ambient temperature and humidity are assessed at the participants' home address using models with fine spatial resolution (1km to 200m, Hough et al 2020) and the SAFRAN model. The forced expiratory volume (FEV1), which is an indicator of bronchial obstruction, is measured by spirometry. The analyses are conducted using a statistical model allowing to identify specific sensitivity windows for temperature and humidity exposure (generalized additive mixed effects model (GAMM) with distributed lags). We will also investigate whether some participants (e.g., asthmatics or asthmatics with specific forms of asthma) are more sensitive to temperature and humidity effects on respiratory health. Preliminary results indicate that an increase in temperature between days 3 and 17 prior to the lung function measurement is associated with a decrease in FEV1.